Collabree is a Swiss-based startup founded in 2020 with a mission to enhance therapy compliance for chronically ill patients. The company's approach, as encapsulated in their slogan "Helping patients to make lasting behavioral changes and stick to their therapy regimen," is underpinned by the belief that adherence interventions can significantly impact population health. The startup leverages behavioral economics principles and combines human engagement with scalable algorithms, incorporating key gamification elements such as fun, friends, and feedback. The innovative platform facilitates patient involvement by offering financial rewards for following therapy plans, participating in health quizzes, and updating vitals. By employing financial, social, and motivational incentives, the company kickstarts behavior change and engenders long-lasting habits. Collabree operates at the intersection of Health Care and Information Technology, seeking to address a critical need in the healthcare industry. The company secured a Fr.280.00K Seed Round investment on 31 January 2021, signaling recognition and support from the investment community. As the startup continues to make strides in improving therapy compliance, its unique approach and technological innovation position it well for potential future growth and impact.
Funding Stage | Amount | No. Investors | Investors | Date |
---|---|---|---|---|
Seed Round | Fr.280.00K | - | 31 Jan 2021 | |
Seed Round | Fr.400.00K | 1 | Evoleen AG | 19 Jun 2020 |
No recent news or press coverage available for Collabree Ltd.